Evidence map›Paper›PMID 37306041›Full record

ArticleEMBO reports2023

MIRO-1 interacts with VDAC-1 to regulate mitochondrial membrane potential in Caenorhabditis elegans.

Xuecong Ren, Hengda Zhou, Yujie Sun, Hongying Fu, Yu Ran, Bing Yang, Fan Yang, Mikael Bjorklund, Suhong Xu

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Xuecong Ren *Center for Stem Cell and Regenerative Medicine and Department of Burns and Wound Repair of the Second Affiliated Hospital, The Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0001-7736-9568
Hengda Zhou *Center for Stem Cell and Regenerative Medicine and Department of Burns and Wound Repair of the Second Affiliated Hospital, The Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-8927-7772
Yujie SunCenter for Stem Cell and Regenerative Medicine and Department of Burns and Wound Repair of the Second Affiliated Hospital, The Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Hangzhou, China.
Hongying FuCenter for Stem Cell and Regenerative Medicine and Department of Burns and Wound Repair of the Second Affiliated Hospital, The Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Hangzhou, China.
Yu RanZhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, China.
Bing YangZhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University, Hangzhou, China.ORCID 0000-0001-6739-2932
Fan YangDepartment of Biophysics and Kidney Disease Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-0520-5254
Mikael BjorklundCentre for Cellular Biology and Signalling, Zhejiang University-University of Edinburgh Institute, Haining, China.ORCID 0000-0002-2176-681X
Suhong XuCenter for Stem Cell and Regenerative Medicine and Department of Burns and Wound Repair of the Second Affiliated Hospital, The Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-4079-340X
Second Affiliated Hospital of Zhejiang University · CNZhejiang Cancer Hospital · CNFirst Affiliated Hospital Zhejiang University · CNWomen's Hospital, School of Medicine, Zhejiang University · CNZhejiang University-University of Edinburgh Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise regulation of mitochondrial fusion and fission is essential for cellular activity and animal development. Imbalances between these processes can lead to fragmentation and loss of normal membrane potential in individual mitochondria. In this study, we show that MIRO-1 is stochastically elevated in individual fragmented mitochondria and is required for maintaining mitochondrial membrane potential. We further observe a higher level of membrane potential in fragmented mitochondria in fzo-1 mutants and wounded animals. Moreover, MIRO-1 interacts with VDAC-1, a crucial mitochondrial ion channel located in the outer mitochondrial membrane, and this interaction depends on the residues E473 of MIRO-1 and K163 of VDAC-1. The E473G point mutation disrupts their interaction, resulting in a reduction of the mitochondrial membrane potential. Our findings suggest that MIRO-1 regulates membrane potential and maintains mitochondrial activity and animal health by interacting with VDAC-1. This study provides insight into the mechanisms underlying the stochastic maintenance of membrane potential in fragmented mitochondria.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsAnimalsMembrane Potential, MitochondrialMitochondriaMitochondrial MembranesMitochondrial Proteinsrho GTP-Binding ProteinsVoltage-Dependent Anion Channel 1Caenorhabditis elegans Proteinsmiro-1 protein, C elegansMitochondrial Proteinsrho GTP-Binding ProteinsVoltage-Dependent Anion Channel 1Caenorhabditis elegansMIRO-1mitochondrial fragmentationmitochondrial membrane potential (ΔΨm)VDAC-1

Identifiers

PMID37306041
PMCPMC10398670
OpenAlexW4380291215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.